Home/Pipeline/Pharmaceutical-Grade Biopolymer Portfolio

Pharmaceutical-Grade Biopolymer Portfolio

Excipient/Component for Drug Delivery, Cell Therapy, Medical Devices

CommercialActive

Key Facts

Indication
Excipient/Component for Drug Delivery, Cell Therapy, Medical Devices
Phase
Commercial
Status
Active
Company

About HTL Biotechnology

HTL Biotechnology is a private, specialty biopolymer company based near Montpellier, France. It has developed a proprietary platform for the sustainable manufacturing of ultra-pure, pharmaceutical-grade biopolymers, which serve as essential excipients and matrices in advanced therapeutics and regenerative medicine. While not a traditional therapeutic developer, its products are enabling components for partners in the biologics and cell therapy spaces, suggesting a B2B platform and services model. The company is likely in a revenue-generating stage, supplying key materials to the pharmaceutical industry.

View full company profile